Harrow Stock

Harrow FCF/Debt

The Free Cash Flow to Debt Ratio of Harrow (HROW) as of Aug 14, 2026 is 17.58 %. In the previous year, Free Cash Flow to Debt Ratio was -27.73 % — a change of -163.41% (higher).

FCF/Debt

17.58 %

YoY

-163.41%

Last updated:

Free Cash Flow to Debt Ratio of Harrow is 2026 17.58 % . Free Cash Flow to Debt Ratio of Harrow was 2025 -27.73 % . It decreases by -163.41% higher compared to the previous year.
Access this data via the Eulerpool API

Harrow Stock analysis

What does Harrow do? Harrow Health Inc is a healthcare company based in San Diego that specializes in the development, manufacturing, and marketing of innovative medical products. The company was founded in 2012 as Imprimis Pharmaceuticals and has since become a significant player in the healthcare market. Harrow is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Harrow stock

Free Cash Flow to Debt Ratio of Harrow is 17.58 % in 2026.

Free Cash Flow to Debt Ratio of Harrow changed from -27.73 % to 17.58 %, representing a -163.41% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio Harrow since 2006 – with annual values, charts, and detailed analysis.

FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's Harrow with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Harrow

All Key Metrics — Harrow